Evidence map›Paper›PMID 35729517›Full record

ArticleBMC psychiatry2022

Catechol-O-methyltransferase activity in individuals with substance use disorders: a case control study.

Jacinto Nuno da Costa Azevedo, Cláudia Carvalho, Maria Paula Serrão, Rui Coelho, Margarida Figueiredo-Braga, Maria Augusta Vieira-Coelho

Abstract read
In one paragraph

Article in BMC psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacinto Nuno da Costa AzevedoDepartment of Neuroscience and Mental Health, Faculty of Medicine, University of Porto, Rua da Alegria 2083, 4200-027, Porto, Portugal. jacintoazevedo@gmail.com.
Cláudia CarvalhoDepartment of Biomedicine-Therapeutics and Pharmacology Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Maria Paula SerrãoDepartment of Biomedicine-Therapeutics and Pharmacology Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Rui CoelhoDepartment of Neuroscience and Mental Health, Faculty of Medicine, University of Porto, Rua da Alegria 2083, 4200-027, Porto, Portugal.
Margarida Figueiredo-BragaDepartment of Neuroscience and Mental Health, Faculty of Medicine, University of Porto, Rua da Alegria 2083, 4200-027, Porto, Portugal.
Maria Augusta Vieira-CoelhoDepartment of Biomedicine-Therapeutics and Pharmacology Unit, Faculty of Medicine, University of Porto, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImpulsivity and substance use disorders (SUD) have been both associated with changes in dopaminergic processes. In this study, we intended to evaluate the dopaminergic function in imprisoned SUD offenders through the determination of s-COMT activity.

methodsThe study included 46 male individuals from a Portuguese penal institution. The participants were assessed through a battery of standardised instruments: Psychopathy Checklist-Revised (PCL-R), Barratt Impulsivity Scale Version 11 (BIS-11), and the European version of the Addiction Severity Index (EuropASI). In addition, s-COMT erythrocyte activity was evaluated.

resultsOverall, 73.9% (n = 34) of the individuals had Antisocial personality disorder (ASPD) and 58.7% (n = 27) presented SUD. We evidenced, for the first time, that, in individuals with SUD, s-COMT activity was correlated with the severity of drug dependence (EuropASI) (p = 0.009), and with BIS-11 factors self-control (p < 0.0001) and non-planning (p = 0.002).

conclusionsThis study opens new perspectives regarding the pharmacological intervention on substance dependence through the interference on dopamine pathways.

Indexed as

Catechol O-MethyltransferaseSubstance-Related DisordersAntisocial Personality DisorderCase-Control StudiesHumansMalePrisonersCatechol O-MethyltransferaseCOMT protein, humanCase-control studyImpulsivityS-COMT activitySubstance use disorders (SUD)

Identifiers

PMID35729517
PMCPMC9210590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.